Rounder, Inc Washington, D.C, has announced the formation of a new division designed to market over the counter nutraceuticals along with medical therapeutic devices.
Norman Birmingham, executive officer at Rounder commented, “We have taken the steps to form this Medical Products Division in anticipation of successfully completing negotiations to purchase and market nutraceutical formulations. The targeted products offer relief of various human maladies, while others are designed to strengthen bones, muscles and further to provide better functions of various human organs.” He continued, “We are excited about our future prospects as the U.S. market for nutraceuticals alone is expected to reach $891 million in consumer purchases by 2013.”